Arrowhead Pharmaceuticals Inc (ARWR)
25.22
+0.22
(+0.88%)
USD |
NASDAQ |
May 08, 16:00
25.21
-0.01
(-0.04%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Market Cap: 3.125B for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 3.125B |
| May 07, 2024 | 3.097B |
| May 06, 2024 | 3.117B |
| May 03, 2024 | 3.028B |
| May 02, 2024 | 2.990B |
| May 01, 2024 | 2.871B |
| April 30, 2024 | 2.803B |
| April 29, 2024 | 2.866B |
| April 26, 2024 | 2.741B |
| April 25, 2024 | 2.710B |
| April 24, 2024 | 2.886B |
| April 23, 2024 | 2.946B |
| April 22, 2024 | 2.964B |
| April 19, 2024 | 2.767B |
| April 18, 2024 | 2.801B |
| April 17, 2024 | 2.791B |
| April 16, 2024 | 2.933B |
| April 15, 2024 | 2.975B |
| April 12, 2024 | 3.060B |
| April 11, 2024 | 3.182B |
| April 10, 2024 | 3.146B |
| April 09, 2024 | 3.252B |
| April 08, 2024 | 3.184B |
| April 05, 2024 | 3.194B |
| April 04, 2024 | 3.235B |
| Date | Value |
|---|---|
| April 03, 2024 | 3.281B |
| April 02, 2024 | 3.245B |
| April 01, 2024 | 3.499B |
| March 28, 2024 | 3.543B |
| March 27, 2024 | 3.556B |
| March 26, 2024 | 3.449B |
| March 25, 2024 | 3.455B |
| March 22, 2024 | 3.371B |
| March 21, 2024 | 3.498B |
| March 20, 2024 | 3.489B |
| March 19, 2024 | 3.441B |
| March 18, 2024 | 3.486B |
| March 15, 2024 | 3.504B |
| March 14, 2024 | 3.397B |
| March 13, 2024 | 3.542B |
| March 12, 2024 | 3.537B |
| March 11, 2024 | 3.643B |
| March 08, 2024 | 4.144B |
| March 07, 2024 | 4.113B |
| March 06, 2024 | 4.386B |
| March 05, 2024 | 4.222B |
| March 04, 2024 | 4.350B |
| March 01, 2024 | 4.470B |
| February 29, 2024 | 3.977B |
| February 28, 2024 | 4.212B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.709B
Minimum
May 13 2019
9.401B
Maximum
Jun 25 2021
4.638B
Average
3.988B
Median
Feb 01 2024
Market Cap Benchmarks
| Madrigal Pharmaceuticals Inc | 4.139B |
| Viking Therapeutics Inc | 8.812B |
| Akero Therapeutics Inc | 1.449B |
| 89bio Inc | 859.88M |
| Sagimet Biosciences Inc | 141.70M |
Market Cap Related Metrics
| PS Ratio | 14.91 |
| PEG Ratio | -0.103 |
| Price to Book Value | 19.48 |
| Price | 25.22 |
| Earnings Yield | -10.98% |
| PEGY Ratio | -0.103 |